Hernu R, Eydoux N, Peiretti A, El-Khoury C, Robert D, Argaud L, Armanet M
Service de réanimation médicale, hospices civils de Lyon, groupement hospitalier Édouard-Herriot, 5, place d'Arsonval, 69437 Lyon cedex 03, France.
Rev Pneumol Clin. 2013 Jun;69(3):126-31. doi: 10.1016/j.pneumo.2013.01.008. Epub 2013 Apr 4.
Acute exacerbations of chronic obstructive pulmonary disease (COPD) patients are major events in the history of this chronic respiratory disease. Their management in French emergency services is unknown, although national guidelines exist.
This is a descriptive audit study, over a 10 weeks period (12/01-22/03/2009), of the management of COPD exacerbations in the RESUVal (Réseau des Urgences de la Vallée du Rhône, France) network emergency departments.
The enrollement of 16 emergency units allowed the analysis of 221 exacerbations of COPD. Measurement of respiratory rate and description of the sputum were mentioned in only 99 (45%) medical records. The rest of the initial assessment was generally satisfactory. Regarding the therapeutic management, 215 (97%) patients received oxygen, beta-2-agonist aerosols were administrated for 209 (95%) patients and anticholinergic aerosols were used for 176 (80%) patients. A systemic corticosteroid and antibiotics were respectively prescribed for 116 (52%) and 123 (56%) patients. Non-invasive ventilation (NIV) was used in only 59% of patients presenting a pH<7.35.
These findings demonstrate that management of exacerbations of COPD could be improved through systematic patients' respiratory rate and sputum characteristics recording or NIV utilization reinforcement.
慢性阻塞性肺疾病(COPD)患者的急性加重是这种慢性呼吸道疾病病程中的重大事件。尽管有国家指南,但法国急诊服务部门对其管理情况尚不清楚。
这是一项描述性审计研究,在10周期间(2009年1月12日至3月22日),对法国罗纳河谷紧急救援网络(RESUVal)急诊科中COPD加重的管理情况进行研究。
16个急诊单元的纳入使得能够对221例COPD加重病例进行分析。仅99份(45%)病历中提到了呼吸频率测量和痰液描述。其余初始评估总体上令人满意。在治疗管理方面,215例(97%)患者接受了氧气治疗,209例(95%)患者使用了β-2激动剂气雾剂,176例(80%)患者使用了抗胆碱能气雾剂。分别有116例(52%)和123例(56%)患者开具了全身用糖皮质激素和抗生素。pH<7.35的患者中仅59%使用了无创通气(NIV)。
这些结果表明,通过系统记录患者的呼吸频率和痰液特征或加强NIV的使用,可以改善COPD加重的管理。